Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies
作者: Fabio EfficaceFrancesco CottoneKathrin SommerJacobien KiefferNeil AaronsonPeter FayersMogens GroenvoldGiovanni CaocciFrancesco Lo CocoGianluca GaidanoPasquale NiscolaMichele BaccaraniGianantonio RostiAdriano VendittiEmanuele AngelucciPaola FaziMarco VignettiJohannes Giesinger
作者单位: 1Italian Group for Adult Hematologic Diseases, Data Center and Health Outcomes Research Unit, Rome, Italy
2Department of Psychosocial Research, Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, The Netherlands
3Division of Applied Health Sciences, University of Aberdeen, Aberdeen, England, UK
4European Palliative Care Research Centre, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
5Department of Palliative Medicine, Bispebjerg Hospital, Copenhagen, Denmark
6Department of Public Health, University of Copenhagen, Copenhagen, Denmark
7Department of Medical Sciences, University of Cagliari, Cagliari, Italy
8Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
9Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
10Hematology Unit, Sant’Eugenio Hospital, Rome, Italy
11Institute of Hematology “L. and A. Seràgnoli,” Departmen
刊名: Value in Health, 2019, Vol.22 (11), pp.1303-1310
来源数据库: Elsevier Journal
DOI: 10.1016/j.jval.2019.06.004
关键词: Confirmatory factor analysisEORTC QLQ-C30Hematologic malignanciesLeukemiaSummary scoreValidation
英文摘要: Abstract(#br)Objectives(#br)We investigated the validity of the recently developed European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) summary score in patients with hematologic malignancies. Specifically, we evaluated the adequacy of a single-factor measurement model for the QLQ-C30, and its known-groups validity and responsiveness to change over time.(#br)Methods(#br)We used confirmatory factor analysis to test the single-factor model of the QLQ-C30, using baseline QLQ-C30 data (N = 2134). The QLQ-C30 summary score was compared to the original QLQ-C30 scales using general (age, sex, Eastern Cooperative Oncology Group performance status, comorbidity) and disease-specific (red blood cell transfusion dependency) groups. Repeated...
全文获取路径: Elsevier  (合作)
影响因子:2.191 (2012)

  • European 欧洲人
  • Core 核心
  • Cancer 巨蟹座